Partner Content Partner Content 6 Ways To Finally Drug RAS Oncogenes Are You Developing Effective Anti-RAS Therapeutics?
Partner Content Partner Content Boehringer Ingelheim to present data at RAS Summit Europe RAS- Targeted Drug Discovery Europe Conference
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
